Your browser doesn't support javascript.
loading
Molecular characterization of breast cancer cell response to metabolic drugs.
Trilla-Fuertes, Lucía; Gámez-Pozo, Angelo; Arevalillo, Jorge M; Díaz-Almirón, Mariana; Prado-Vázquez, Guillermo; Zapater-Moros, Andrea; Navarro, Hilario; Aras-López, Rosa; Dapía, Irene; López-Vacas, Rocío; Nanni, Paolo; Llorente-Armijo, Sara; Arias, Pedro; Borobia, Alberto M; Maín, Paloma; Feliú, Jaime; Espinosa, Enrique; Fresno Vara, Juan Ángel.
Affiliation
  • Trilla-Fuertes L; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
  • Gámez-Pozo A; Biomedica Molecular Medicine SL, Madrid, Spain.
  • Arevalillo JM; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
  • Díaz-Almirón M; Biomedica Molecular Medicine SL, Madrid, Spain.
  • Prado-Vázquez G; Operational Research and Numerical Analysis, National Distance Education University (UNED), Madrid, Spain.
  • Zapater-Moros A; Biostatistics Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain.
  • Navarro H; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
  • Aras-López R; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
  • Dapía I; Operational Research and Numerical Analysis, National Distance Education University (UNED), Madrid, Spain.
  • López-Vacas R; Congenital Malformations Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital, IdiPAZ, Madrid, Spain.
  • Nanni P; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain.
  • Llorente-Armijo S; Biomedical Research Networking Center on Rare Diseases-CIBERER, ISCIII, Madrid, Spain.
  • Arias P; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
  • Borobia AM; Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland.
  • Maín P; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
  • Feliú J; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain.
  • Espinosa E; Biomedical Research Networking Center on Rare Diseases-CIBERER, ISCIII, Madrid, Spain.
  • Fresno Vara JÁ; Clinical Pharmacology Department, La Paz University Hospital School of Medicine, IdiPAZ, Autonomous University of Madrid, Madrid, Spain.
Oncotarget ; 9(11): 9645-9660, 2018 Feb 09.
Article in En | MEDLINE | ID: mdl-29515760

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2018 Type: Article